Trichophyton indotineae is a recently-emerged fungus causing severe cases of ringworm across the world that often fail first-line therapy. This paper provides comprehensive analyses of the largest United States cohort of Trichophyton indotineae infections. ja.ma/3yi860F

Today, Clara BEKIRIAN brilliantly defended her PhD on #Candida albicans cell wall INSTITUT PASTEUR 🍄. What a didactic talk on the complexity of the cell wall structure with a focus on B-1,6-glucans ! 👏

🔬Félicitations au Dr Emmanuel Dudoignon, praticien hospitalier en réanimation chirurgicale, lauréat du dispositif PH recherche pour son étude sur les infections fongiques chez les grands brûlés à l’hôpital Saint-Louis Découvrez ses travaux de recherche 👉bit.ly/4bWP9zl

🧫A wonderful new study showing infections never play solo. 🦠Whether viral, fungal, or bacterial, or all together, interactions must be studied. 🍄With maybe the host as the key to unlocking the mystery?! #CAPA #IDtwitter ATS Blue Journal Simon Feys jannesheylen Agostinho Carvalho

🔥🔥🔥 Last night, AJRCCM ATS Blue Journal published our latest research comparing bacterial versus Aspergillus superinfections in patients with severe influenza or COVID-19! A thread 🧵(1/15) atsjournals.org/doi/abs/10.116…

🆕📜Emerging issues in dermatophytosis 1/ Deep 2/ Extensive 👉 Trichophyton Indotineae 3/ Resistant 💊 4/ Sexually transmitted 5/ Shifting epidemiology of zoonotic cases Research priorities ↓↓ w/ Arnaud Jabet Ali Abdolrasouli 🔗bit.ly/3xjxxiw

🆕📰 Risk factors and outcome associated with #fungal 🍄 infections in patients with severe #burn injury 🔥 → Our 10 year IFI-BURN from Hôpital Saint-Louis AP-HP study with Emmanuel Dudoignon just out in @CIDjournal Stay tuned, more to come… ! In long 👉 doi.org/10.1093/cid/ci… In short👇

🔔ORAL amphotericin B formulation (MAT2203)🔔Compassionate use in 5 cases (Rhodotorula, Candida krusei, Fusarium² and Histoplasma) -> in an area of azole resistance, coinfections and increase of non-Aspergillus mould infections something to keep an eye on. academic.oup.com/ofid/article/d…

It is an exciting time for clinical mycology There are expanding patient populations at risk of fungi, emerging drug-resistant pathogens, & promising new antifungals on the horizon We wrote about it 👇 Big thanks Jessica Little, MD & co-authors, & to Martin Hoenigl🇺🇦🇦🇹 & John Baddley

Dear friends, Im sharing with you information about this amazing Medical Mycology Course 2025 from the Pasteur Institute pasteur.fr/en/education/p…

🆕📄 The emerging 🍄 pathogen Trichophyton #indotineae is hard to distinguish from other T. mentagrophytes complex species. 🧬 We’ve developed a new #qPCR assay for rapid detection from clinical samples (1-2 days) 🔗 doi.org/10.1093/mmy/my…

How to deal with and what is the impact of some recently described phenotypes in C. neoformans. See this review work from great researchers from our Pasteur group: #PLOSPathogens: Population heterogeneity in Cryptococcus neoformans: Impact on pathogenesis dx.plos.org/10.1371/journa…

Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies and management challenges EFISG incl M Giannella, Lanternier Fanny, Sarah Dellière Andreas Groll Nic Mueller Ana Alastruey monica slavin clinicalmicrobiologyandinfection.com/article/S1198-…

🎓 Les inscriptions du DU des Agents #Infectieux à l'ère de la #Génomique sont ouvertes. Une formation à ne pas louper ! Section Des Jeunes Microbiologistes de la SFM 👀 🎲 Avec Maud Salmona, nous vous avons concocté pour le dernier module, un petit Escape Game pédagogique autour d'outils de bio-informatique 🧟‍♀️💻